findmyKOL
Clinical trialNCT01819766CompletedObservational

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

SponsorExact Sciences CorporationEnrollment440Colorectal CancerColorectal NeoplasmsInflammatory Bowel Disease (IBD)Primary Sclerosing Cholangitis (PSC)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study aims to determine the performance of the Exact IBD-ACRN surveillance test to detect colorectal cancer (CRC) and colorectal neoplasia in patients with inflammatory bowel disease (IBD). Patients with an IBD diagnosis for at least eight years or diagnosis of primary sclerosing cholangitis (PSC) and who are eligible for CRC screening are eligible to participate in this study. Enrolled subjects will collect a stool sample for the Exact IBD-ACRN surveillance test. Subjects must have undergone colonoscopy no more than 90 days prior to enrollment and will undergo colonoscopy or surgical intervention within 120 days of enrollment. Tissue diagnosis of CRC will be established by histopathologic examination.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Calgary

    Calgary, Alberta, Canada

  • Winnipeg Regional Health Authority-Health Sciences

    Winnipeg, Manitoba, Canada

United States
  • Mayo Clinic Arizona

    Phoenix, Arizona, United States

  • Uc San Diego Medical Center

    La Jolla, California, United States

  • University of Miami

    Miami, Florida, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • University of Chicago Medicine

    Chicago, Illinois, United States

  • Northshore University Health System

    Evanston, Illinois, United States

  • Gastroenterology Associates, Llc

    Baton Rouge, Louisiana, United States

  • Mgg Group, Co. Inc./chevy Chase Clinical Research

    Chevy Chase, Maryland, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Detroit Clinical Research Center, Pc

    Farmington Hills, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Center for Digestive and Liver Diseases, Inc

    Mexico, Missouri, United States

  • Medical Research Associates of New York

    New York, New York, United States

  • Mount Sinai School of Medicine

    New York, New York, United States

  • Asheville Gastroeneterology Associates

    Asheville, North Carolina, United States

  • Univeristy of North Carolina

    Chapel Hill, North Carolina, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Houston Methodist Hospital

    Houston, Texas, United States

  • Advanced Research Institute

    Logan, Utah, United States

  • Blue Ridge Medical Research

    Lynchburg, Virginia, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, United States

  • Wisconsin Center for Advanced Research

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2013
Primary completion
31 Jan 2017
Completion
31 Jan 2017
Last update posted
17 Feb 2017
Registered enrollment
440
Registry id
NCT01819766

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.